Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S 3 Fluorophenylethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115448813B details a manganese-catalyzed route for Crizotinib intermediates. Achieves 95% ee with reduced costs and scalable mild conditions for global supply chains.
Patent CN105087668A reveals high-yield biocatalytic route for chiral intermediates. Achieve cost reduction and supply reliability with green manufacturing processes.